Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variants are linked to a higher risk of polycystic ovary syndrome, hair loss, and obesity in women from western Saudi Arabia.

PCOS patients have more central body fat, which can be effectively measured using DEXA.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Metformin is less effective in men with early-onset hair loss.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Resistance training improved BMI and menstrual regularity more in women with PCOS than aerobic training.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Men with male pattern baldness had higher body fat and obesity-related measurements but similar heart fat and artery thickness compared to healthy men.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Low-dose flutamide-metformin therapy effectively improved PCOS symptoms in adolescent girls.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.